• No products in the list

FlashDx – Respiratory Panel 1.1

Short description

In a world where accurate and rapid diagnostics are crucial for effective patient care, FlashDx’s Respiratory Panel 1.1 stands as a remarkable leap forward. The expanded range of pathogens, coupled with its seamless sample extraction process, ensures that healthcare providers can make informed decisions swiftly and confidently.

Contact us today to schedule a demonstration and learn more about how this breakthrough technology can transform your practice

Product highlights

  • Sars-CoV-2
  • Influenza A and B
  • Adenovirus
  • Respiratory Syncytial Virus
  • Human Rhinovirus/Enterovirus
  • Bordetella pertussis
  • Human Metapneumovirus
  • Parainfluenza virus 1, 2, and 3
  • Mycoplasma pneumoniae

Ask for a quote

FlashDx – Respiratory Panel 1.1




For any missing information or if you require additional details, please do not hesitate to contact us. 

Specifications of the FlashDx – Respiratory Panel 1.1

Introducing FlashDx’s Enhanced Respiratory Panel 1.1: Simultaneous Testing for an Expanded Range of Pathogens

In the realm of Point-of-Care Testing (POCT), innovation is a driving force that continually transforms the landscape of medical diagnostics. FlashDx, a pioneer in rapid and accurate diagnostic solutions, is proud to announce a groundbreaking enhancement to their existing Respiratory Panel 1.0. The newly introduced Respiratory Panel 1.1 takes the capabilities of POCT to new heights by incorporating an extended array of pathogens. This expansion enables healthcare professionals to swiftly and precisely perform a battery of tests, making diagnostic processes more efficient and comprehensive.

Expanding the Horizon: Respiratory Panel 1.1

The Respiratory Panel 1.1 by FlashDx is a testament to the commitment towards better patient care. Building upon the success of the original panel, this upgraded version now encompasses an even wider spectrum of pathogens. The enhanced panel empowers medical practitioners to simultaneously test for an array of infectious agents, including:

– Sars-CoV-2
– Influenza A and B
– Adenovirus
– Respiratory Syncytial Virus
– Human Rhinovirus/Enterovirus
– Bordetella pertussis
– Human Metapneumovirus
– Parainfluenza virus 1, 2, and 3
– Mycoplasma pneumoniae

The inclusion of these additional pathogens ensures a more comprehensive assessment, enabling medical professionals to swiftly identify the root cause of respiratory illnesses. This level of diagnostic accuracy is paramount, especially in environments where prompt decision-making can have a significant impact on patient outcomes.

Revolutionizing Sample Extraction

One of the standout features of the enhanced Respiratory Panel 1.1 is its seamless sample extraction process. FlashDx has integrated a sample extraction method that is not only efficient but also user-friendly. With the integration of this technology, the extraction process has become so straightforward that it can be completed in less than a minute. Whether it’s a nasopharyngeal, nasal, or throat swab, the FlashDx solution simplifies the complex, making it accessible even to those with minimal technical expertise. This advancement in sample extraction ensures that healthcare providers can focus on delivering care rather than grappling with cumbersome procedures.

Demo Instruments and Further Information

As a testament to the confidence in the capabilities of the FlashDx Respiratory Panel 1.1, demo instruments are readily available for interested healthcare institutions. We believe in the value of seeing firsthand how this innovation can revolutionize your diagnostic processes. Our team is enthusiastic about providing in-depth explanations and demonstrations of the panel’s features. We are more than willing to arrange visits and discussions at your convenience, allowing you to explore the possibilities firsthand.


Components of the FlashDx – Respiratory Panel 1.1

The kit includes tests for Sars-CoV-2, Influenza A/B, Adenovirus, RSV, Rhinovirus, Bordetella, Metapneumovirus, Parainfluenza, and Mycoplasma.

Explore Related Items